We wanted to see if the timing affects us at all," said Edena Khoshaba, lead investigator and medical student.

Guardant Health’s blood test designed to help screen the population for hidden cases of colorectal cancer may have taken a ...

WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and ...

Atalanta won their first major trophy in 61 years as a stunning hat-trick from footballer Ademola Lookman ended Bayer ...

The PressureSafe device reduced the incidence of pressure injuries by 50% by detecting these pressure injuries to the skin ...

CPAs are the result of gene mutations leading to the development of two-layer nodules that have tumor-inducing and ...

Results from the study showed that the cell-free DNA blood-based test had a sensitivity of 83.1% for CRC and a specificity of ...

Agency scientists highlighted the risk in materials posted ahead of a Thursday advisory panel meeting for the Guardant Health blood test.

While propofol sedation is associated with improved serrated polyp detection, propofol sedation may not improve adenoma detection. Propofol sedation during a colonoscopy is associated with increased ...

Guardant Health (GH) stock fell after FDA reviewers expressed concerns about its Shield blood test for colorectal cancer ...

Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, unveiled key findings from its groundbreaking eAArly DETECT study during a ...

Higher endoscopist polyp detection rates were significantly associated with fewer negative colonoscopies after positive stool ...